Arcanobacterium haemolyticum, a pathogen of the human upper respiratory tract and other systems, has been reported to produce soluble toxins, including a phospholipase D (PLD). We confirmed production of PLD by this organism and cloned and sequenced pld. Arcanobacterial. PLD (PLD-A) was found to be a protein of =31.5 kDa with a pI of z9.4. Cosmid cloning, followed by subcloning into phagemid pBluescriptIISK+, yielded Escherichia coli(pAhl4O), a recombinant with a gene product corresponding to PLD-A. Evidence of PLD activity was found by three assays in supernatant fluid of cultures ofE. coli(pAhl40) and A. haemolyticum, but not in E. coli(pBluescriptlISK+). Experiments to determine if this protein was secreted were not conducted, but previous work with PLD from Corynebacterium pseudotuberculosis suggested that the presence of the enzyme in culture supernatant fluids was due to lysis ofE. coli rather than to active transport. Antibodies in polyclonal sera from goats immunized with native or recombinant PLD-A neutralized native and recombinant PLD-A activity, and antibodies against native or recombinant PLD from C. pseudotuberculosis (PLD-P) partially neutralized native and recombinant PLD-A. Antibodies prepared against recombinant PLD-A labelled both recombinant and native PLD-A in Western blots (immunoblots) and dot blots, but antibodies against PLD-P did not. Sequencing of the insert in pAhl4O revealed an open reading frame of 930 bp coding for 309 amino acids, including a putative signal sequence of 26 amino acids (3.2 kDa, determined on the basis of homology with the 24-amino-acid signal sequence ofpld from C. pseudotuberculosis bv. ovis) and the mature PLD protein (31.5 kDa). Sequence comparisons of coding regions revealed 65% DNA homology with pld genes from C. pseudotuberculosis and Corynebacterium ulcerans. Comparison of amino acid sequences revealed 64% homology of PLD-A both with PLD-P and with PLD produced by C. ulcerans.
PLD-A labelled both recombinant and native PLD-A in Western blots (immunoblots) and dot blots, but antibodies against PLD-P did not. Sequencing of the insert in pAhl4O revealed an open reading frame of 930 bp coding for 309 amino acids, including a putative signal sequence of 26 amino acids (3.2 kDa, determined on the basis of homology with the 24-amino-acid signal sequence ofpld from C. pseudotuberculosis bv. ovis) and the mature PLD protein (31.5 kDa). Sequence comparisons of coding regions revealed 65% DNA homology with pld genes from C. pseudotuberculosis and Corynebacterium ulcerans. Comparison of amino acid sequences revealed 64% homology of PLD-A both with PLD-P and with PLD produced by C. ulcerans.
Arcanobacterium (Corynebacterium) haemolyticum was originally associated with outbreaks of pharyngitis in humans (21, 22, 24) . Evidence supporting a role for this organism as an etiologic agent of pharyngitis includes its isolation as the sole or predominant species in the absence of other recognized bacterial pathogens, its absence from follow-up cultures of recovered patients (3, (24) (25) (26) (27) 31) , and the presence of high titers of specific antibody in clinical cases (11, 47) . Failure of some investigators to exclude viral pathogens has left the primary etiologic role ofA. haemolyticum in doubt (30) , and it is possible that A. haemolyticum behaves as an opportunistic pathogen.
Pharyngitis and cutaneous infections are the most common clinical syndromes associated with A. haemolyticum infection; most of the 150 strains isolated by MacLean and coworkers (24) came from such infections. Most patients thought to have had A. haemolyticum pharyngitis have been young adults presenting with a sore throat, cervical lymphadenopathy, or skin rash. Pharyngitis has been of variable severity, at times mimicking that produced by Streptococcus pyogenes (24, 31) and Corynebacterium diphtheriae (11, 12, 17) . The erythematous rash observed in half of involved patients has often been a predominant manifestation of disease. Other signs of systemic toxicity, such as fever and * Corresponding author. Electronic mail address: gsonger@ccit.
arizona.edu. leukocytosis, have usually been mild or absent altogether, although A. haemolyticum infection has been misdiagnosed as staphylococcal toxic shock syndrome (43) . Isolates of A. haemolyticum have also been obtained from wound infections (22) , chronic skin ulcers (24) , and brain abscesses (1, 7, 46) and in cases of vertebral osteomyelitis (6) and bacteremia (4, 7, 16) .
Toxin production by A. haemolyticum has been reported but remains a subject of controversy. Neither MacLean and coworkers (24) nor Hermann (13) could demonstrate filterable toxins, but in the 1960s, Czechoslovakian investigators published several reports of toxic substances in culture filtrates of A. haemolyticum (29, 37, 38, 40) . A toxin or toxins with dermonecrotic and lethal properties appeared in culture supernatant fluids at the beginning of the exponential phase of growth and remained stable for long periods, including during storage at 4°C for at least 1 month (29) . In preparations partially purified by ammonium sulfate precipitation or adsorption onto red blood cells, the Czechoslovakian investigators found activity which dissolved egg yolk, hydrolyzed Tween 20, and released choline from lecithin (the last suggesting phospholipase D [PLD] activity) (38) . Soucek and coworkers (40) reported that a substance in culture supernatant fluids inhibited the lytic action of ,3-toxin of Staphylococcus aureus, and the description of the active substances in culture supernatant fluids was expanded to include three elements. An a component possessed lecithinase activity, dermonecrotic activity, and 3-hemolysin-inhibiting activity (40) ; adsorbed to erythrocytes; and dissolved egg yolk (39) . A ,B component lysed erythrocytes (39) , and a r component possessed lipase activity, possibly corresponding to phospholipase A activity (39) .
Phospholipases may be important in the pathogenesis of diseases caused by other bacteria, including Photobacterium (Vibrio) damsela, Clostridium perfringens, Clostridium novyi type D, Pseudomonas aeruginosa, S. aureus, and coryneform organisms such as Corynebacterium pseudotuberculosis and Corynebactenum ulcerans (5, 10, 18, 22, 23, 28, 35, 36, 41, 42, 44) . Results of in vivo studies with Pldmutants strongly suggest a role for PLD in the pathogenesis of C. pseudotuberculosis infections in sheep and goats (reference 15 and unpublished results), and our work with this organism has led to an interest in toxic PLDs in general. The PLD genes and gene products from C. pseudotuberculosis and C. ulcerans have 80% DNA sequence homology and 87% amino acid sequence homology, and the enzymes are antigenically related, as determined by Western blotting (immunoblotting) of the enzyme from C. ulcerans with serum prepared against PLD from C. pseudotuberculosis (unpublished results). A. haemolyticum is similar to pathogenic corynebacteria in many respects and has been considered, until recently, a member of the genus Corynebacterium (8, 9) . Strains ofA. haemolyticum producing relatively more of the a toxic component (as noted above, possibly a PLD) were often from patients with the most severe manifestations of the disease (37), suggesting a role for the a component in pathogenesis of A. haemolyticum infections. As an initial step in determining the role of PLD in A. haemolyticum infections and to add to our knowledge of the structure of genes for bacterial toxic phospholipases, we confirmed PLD production by A. haemolyticum and cloned pld from this organism, expressing the gene in Escherichia coli.
MATERIALS AND METHODS
Assays of PLD activity. To determine whether the enzyme was specifically PLD rather than phospholipase C, a modification of a procedure for determination of phospholipid concentrations in serum and plasma was used (45 were added; the reaction mixtures were vortexed for 15 s and incubated at 37°C for 10 min; and the optical densities at 505 nm were determined by using color reagent as a blank and purified PLD-P (10) and Clostridium perfringens a toxin (Sigma) as controls. All assays were performed in duplicate. In this assay, PLDs produce measurable color change above background values, while phospholipases C produce no color change.
Purification of PLD from A. haemolyticum. PLD from A.
haemolyticum ATCC 9345 (PLD-A) was purified to apparent homogeneity for comparison with the recombinant gene product. Briefly, culture supernatant fluids (from 500 ml of brain heart infusion broth culture in 1-liter Erlenmeyer flasks, incubated for 48 h at 37°C, with shaking at 250 rpm)
were dialyzed against 20 liters of high-pressure liquid chromatography-grade water, lyophilized, and dissolved in 10 ml of 1 M urea-10% ethylene glycol-150 mM NaCl-200 mM Tris HCl (pH 7.0). This material was fractionated on a Pharmacia C 26/100 column packed with Bio-Gel P-100 (Bio-Rad Laboratories, Richmond, Calif.), eluting with the same buffer at 40 ml/h in 5-ml fractions. Fractions with the highest synergistic hemolytic and 3-toxin-inhibiting activities were pooled and dialyzed completely against water. Ammonium sulfate, sodium chloride, and disodium phosphate were added to final concentrations of 0.75 M, 77 mM, and 67 mM, respectively, and the pH was adjusted to 7.0. This material was applied to a Pharmacia C 10/40 column packed with phenyl Sepharose CL-4B (Pharmacia-LKB Biotechnology, Alameda, Calif.) which had been equilibrated with 0.75 M (NH4)2SO4-77 mM NaCl-67 mM Na2HPO4 (pH 7.0). Elution was isocratic at 10 ml/h, in 5-ml fractions.
Fractions with synergistic hemolytic and 13-toxin-inhibiting activities were pooled, concentrated 20-fold by ultrafiltration (Amicon stir-cell and YM10 membrane; Amicon, Danvers, Mass.), and dialyzed against 0.9 M NaCl-10% glycerol-0.1 M Tris HCl (pH 7.5). Portions (7 ml) were fractionated on a Pharmacia C 16/100 column packed with Bio-Gel P-60 (BioRad), eluting with the same buffer at 20 ml/h in 5-ml fractions. Fractions were examined by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (19) and synergistic hemolytic and 13-toxin inhibition assays. The isoelectric point was determined by using a gradient of pH 3 to 10 in a Rotofor isoelectric focusing cell (Bio-Rad) (10) . Preparation of arcanobacterial DNA. The washed cell pellet harvested from a 500-ml culture ofA. haemolyticum in brain heart infusion broth was suspended in 2.5 mM Tris-2.5 mM EDTA-0.5 M sucrose (pH 8.0) with 10 mg of lysozyme (Sigma) per ml. After incubation at 37°C for 4 h, the protoplasts were harvested by centrifugation and the pellet was suspended in 5 mM Tris-5 mM EDTA-1% SDS (pH 7.4) and incubated at 50°C for 30 min. Cell debris and protein were removed by repeated extraction with 100 mM Trissaturated phenol (pH 8.0), phenol-chloroform-isoamyl alcohol, and chloroform-isoamyl alcohol. After precipitation with ethanol and drying, the DNA was dissolved in 7 M guanidine hydrochloride (Bethesda Research Laboratories, Gaithersburg, Md.) in Tris-EDTA (pH 8.0) and the mixture was incubated at 55°C for 2 h. The DNA was then precipitated twice with ethanol, the second time in the presence of 0.1 volume of 3 M sodium acetate (pH 5.0). DNA was prepared by the same method from C ulcerans, from isolates of biovars equi and ovis of C. pseudotuberculosis (35) , and from Actinomyces (Corynebacterium) pyogenes.
Construction of the arcanobacterial cosmid library. Cosmid pLAFR2 was prepared by alkaline lysis (32) of E. coli LE392 cultivated in Luria-Bertani broth containing 15 ,ug of tetracycline per ml. Cosmid DNA was purified by centrifugation on a cesium chloride gradient (55,000 rpm, 20°C; VTi 65 rotor; Beckman Instruments, Fullerton, Calif.), digested with BamHI (Promega Biotec, Madison, Wis.), dephosphorylated with calf intestinal alkaline phosphatase (Promega), phenol-chloroform-isoamyl alcohol extracted, and ethanol precipitated (32) . About 50 p,g of arcanobacterial DNA was partially digested with Sau3A (Promega) to yield fragments 17 to 30 kb in length (34, 36) . These fragments were mixed with the prepared cosmid DNA in a final molar ratio of 3:1 and ligated by using T4 DNA ligase (Promega) at 16°C for 16 h. A 10-,ul aliquot of the ligation mixture was packaged with (33) . Proteins in some unstained gels were electrotransferred to nitrocellulose membranes (Bio-Rad) and probed with immune goat serum diluted 1:250 followed by a rabbit anti-goat immunoglobulin G-peroxidase conjugate (Kirkegaard & Perry, Gaithersburg, Md.) diluted 1:1,000. Blots were incubated with peroxidase substrate (Bio-Rad) at room temperature for 5 min (36) following biotin-streptavidin amplification (BLAST System; New England Nuclear).
Neutralizing antibody assay. Aliquots (45 ,ul) of culture supernatants containing native and recombinant PLD-P and PLD-A were mixed with 5-,1 aliquots of sera taken from goats immunized with culture supernatants containing either PLD-A or PLD-P. Sera from nonimmunized goats were used as controls. After incubation at 37°C for 1 h, 10-,ul portions of each mixture were placed into wells cut into immunodiffusion plates containing blood agar and 10% equi factors, as previously described (36) . Plates were incubated at 37°C for 16 h, and zones of synergistic hemolysis were measured. Zone size was decreased in the presence of normal serum, and values resulting from neutralization tests were adjusted accordingly. This effect of normal serum may have been due to interaction of PLD with serum phospholipids. It may also be due to the presence of endogenous neutralizing antibodies, but the phenomenon is seen with serum from goats and sheep from flocks with no history of caseous lymphadenitis and is also seen with serum from normal rabbits. PLD-serum mixtures were also assayed for PLD activity by using the radiometric sphingomyelinase assay previously described.
Nucleotide sequence accession number. The sequence of pld from A. haemolyticum has been assigned GenBank accession number L16583.
RESULTS AND DISCUSSION
PLD production by A. haemolyticum. Purification methods described yielded PLD-A purified to homogeneity or near homogeneity, as judged by examination of the purified material in SDS-polyacrylamide gels with silver staining (Fig. 1) . No step-by-step estimates of efficiency of the purification process were made, but the final material had been purified =150-fold and had a specific activity of 1,096 U/mg. Use of the colorimetric assay (45) confirmed that this molecule possessed PLD activity.
PLD-A was similar to PLD-P in molecular mass (=31.5 kDa for PLD-A [ Fig. 1] and -31.7 kDa for PLD-P [10, 20] ) as determined by SDS-PAGE and from pl (=9.4 for PLD-A (data not shown) and =9.8 for PLD-P [10, 20] ). In isoelectric focusing experiments, most of the PLD-A activity focused at pH 9.4. Unlike PLD-P (11), PLD-A did not focus sharply at its apparent isoelectric pH, and we experienced difficulty in separating PLD-A from other arcanobacterial proteins which focused at this pI. Thus, we were unable to use preparative isoelectric focusing for routine purification. The basis for this result is unknown, but it could possibly be due to the occurrence of multiple isoforms of PLD-A. Antibodies prepared against whole supernatant fluid from E. coli(pAhl4O) labelled many proteins in supernatant fluids from cultures of E. coli(pBluescriptIISK+) and one additional protein in supernatant fluids from cultures of E. coli(pAhl4O) (Fig. 2, lanes 1 and 2) . In supernatant fluid from cultures of A. haemolyticum, a protein of =31.5 kDa, corresponding to the molecular mass of PLD-A, was labelled (Fig. 2, lane 3) . The cum in gel diffusion assays has also been reported by others (29) .
Although A. haemolyticum is hemolytic when grown on blood agar, we did not encounter independent hemolytic activity in fractions at any step in the purification process. Screening of several independent libraries, representing =50-fold coverage of the genome of A. haemolyticum, did not reveal any recombinant producing an independently hemolytic gene product. Thus, we cannot confirm other findings (39, 40) regarding production of a hemolysin by this organism, but these results parallel those from our studies with C. pseudotuberculosis (36) and suggest, while not confirming, that A. haemolyticum does not produce a hemolysin independent of PLD-A. On the other hand, if an oxygen-labile hemolysin was present, it might have gone undetected by our methods. It may also be that A. haemolyticum produces sufficient hemolysin to lyse erythrocytes on a plate but insufficient quantities to be detected in our assay (the 3-toxin inhibition assay before addition of staphylococcal ,B-toxin).
Cloning and characterization ofpld from A. haemolyticum. Cosmid cloning, followed by subcloning into phagemid pBluescriptIISK+, yielded E. coli(pAhl40), a recombinant with a gene product corresponding to PLD-A. On the basis of estimates of the molecular weight of PLD-A (see above), the 1.4-kb insert in pAhl40 was determined to be sufficient to span the structural gene and accessory sequences.
To confirm that pAhl40 contained pld, PLD activities in E. coli(pAhl40), E. coli(pBluescriptIISK+), and A. haemolyticum ATCC 9345 were compared. First, culture supernatant fluids were examined for synergistic hemolytic, 1-toxin-inhibiting, and PLD activities. Supernatant fluids from cultures of E. coli(pAhl40) and ofA. haemolyticum, but not from cultures of E. coli(pBluescriptlISK+), exhibited synergistic hemolytic and 13-toxin-inhibiting activities, both of which are characteristic of PLD-P (36) . Supernatant fluids from cultures of E. coli(pAhl40) and of A. haemolyticum, examined by the radiometric assay for release of labelled choline moiety from [14C]sphingomyelin, contained PLD activity, but no activity was produced by E. coli(pBluescript-IISK+). Detection of PLD activity in supernatants of cultures of E. coli(pAhl40) does not imply active transport of the enzyme by E. coli. Experiments were not done to confirm this, but earlier experience with the PLD gene from C. pseudotuberculosis, cloned into E. coli, showed that most recombinant PLD activity remained in association with the bacterial cells (36) .
Second, purified native PLD and supernatant fluids from cultures of A. haemolyticum and of E. coli(pAhl40) were examined by SDS-PAGE and Western blotting ( Fig. 1 and  2) . A major product of E. coli(pAhl40), which was labelled by goat anti-recombinant-PLD-A antibodies, had a molecular size of =31.5 kDa and was present in lanes loaded with E. coli(pAhl40) supernatant fluid but not in lanes loaded with that of E. coli(pBluescriptlISK+) (Fig. 2) . Other protein bands were detected but were identical in molecular size to labelled bands present in lanes loaded with supernatant fluid from E. coli(pBluescriptIlSK+). Anti-recombinant-PLD-A antibodies also labelled a -31.5-kDa product present in supernatant fluids from cultures ofA. haemolyticum (Fig. 2) .
The discrepancy between molecular sizes of recombinant and native PLD-A may be due to a lack of posttranslational modification of recombinant PLD-A, specifically, to a lack of signal sequence cleavage.
Third, the ability of antibodies in polyclonal sera from immunized goats to neutralize PLD-A activity was deter- On the basis of (i) production of PLD by E. coli(pAhl40), (ii) neutralization of native and recombinant PLD by goat anti-PLD sera, (iii) antibody labelling of native and recombinant proteins of similar molecular mass, and (iv) lack of evidence for other synergistically hemolytic or sphingomyelin-hydrolyzing proteins in A. haemolyticum, the =31.5-kDa protein produced by E. coli(pAhl40) must be PLD-A and pld must be contained in pAhl40.
Comparison of the restriction maps of pld from A. haemolyticum (not shown) and from C. pseudotuberculosis (36) bp coding for 309 amino acids, including a putative signal sequence of 26 amino acids (3.2 kDa, determined on the basis of homology with the 24-amino-acid signal sequence of pld from C. pseudotuberculosis bv. ovis) (14) and the mature PLD protein (31.5 kDa). Thus, the pld protein from C. pseudotuberculosis and the pld protein from A. haemolyticum are each apparently composed of 283 amino acid residues (14) . Confirmation of these observations would require N-terminal amino acid sequencing, which was not 1 GCA AAG TGT AAC GGT CAA CAT AGA GAC ATG GM GAG AAC ACC ACA GGT TCT GM AM CAT (-35) .. ( -10)   61 TGT GM TAT TTC TCT TTC ATC ATA TM ATA CAC MT TTT ATC CTT MC CGG ATG GGC TTC   121 GCA GM AGA TGT ACG ACG ATG MG ACG CGG AA AAA ATT GCT TTA GCC TTG TCG CTT with HindIII (data not shown). The inconsistency between the size of the HindIII subcloned insert used as a probe and the size of the HindIII-digested chromosomal band with which it hybridized remains unexplained but may be due to the presence of restriction sites in arcanobacterial DNA which are cleaved only when prepared in E. coli. This may be due to the presence of a DNA modification system in A.
haemolyticum which is absent in E. coli DH5a
Under conditions of high stringency, Southern blot analysis demonstrated no homology between the internal pld fragment and chromosomal DNA from C. ulcerans, C. pseudotuberculosis, and Actinomyces pyogenes. However, at lower stringency (80 to 85%), a single band of 1.8 kb was observed in lanes containing HincII-digested chromosomal DNA from C. pseudotuberculosis bv. equi and ovis. This result was as predicted, in that the genes coding for PLD in the two C. pseudotuberculosis biovars were found on 1.8-kb HincII DNA fragments (reference 36 and unpublished results).
The results are useful in that they confirm the production of PLD byA. haemolyticum and reveal similarities between PLD-A, PLD-P, and PLD produced by C. ulcerans. Lack of significant DNA homology between these pld genes and sequences in GenBank may imply unique structural features within this group of enzymes. Comparisons with sequences of eukaryotic PLDs, when these become available, may be of interest. Further study of the genes, by site-directed mutagenesis and other methods, may reveal aspects of structure and function which will contribute to our understanding of the various in vitro correlates of PLD activity (e.g., whether PLD, synergistic hemolysis, and P-hemolysin inhibition are one and the same or arise from two or more different molecular domains) and perhaps suggest a role of these enzymes in pathogenesis of infections by the respective organisms.
